Ca2+-dependent lipid scrambling and ion transport by TMEM16 proteins
TMEM16 蛋白的 Ca2 依赖性脂质扰乱和离子传输
基本信息
- 批准号:8728513
- 负责人:
- 金额:$ 57.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-04 至 2018-02-28
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAnionsApoptosisApoptoticBindingBinding SitesBiochemicalBiological AssayBlood PlateletsBlood coagulationCationsCell LineCell membraneCell physiologyCell surfaceCellsChimera organismDataDefectDependenceDiseaseElementsEtiologyFamilyGoalsHemorrhageImpairmentInheritedIon ChannelIon TransportIonsKnockout MiceLightLipidsMeasurementMeasuresMediatingMolecularMutationOsteogenesisPathway interactionsPhagocytesPhenotypePhosphatidylserinesPhospholipidsPhysiologic calcificationPhysiologicalProcessProteinsRegulationReportingResearch PersonnelRoleScott syndromeSiteSurfaceSystemTestingTransmembrane DomainWorkbasedesigninsightlipid transportmembermutantprotein functionpublic health relevancereconstitutionresearch study
项目摘要
DESCRIPTION (provided by applicant): Phosphatidylserine (PS) is normally sequestered in the inner leaflet of the plasma membrane and its surface exposure triggers blood clotting by activated platelets and marks apoptotic cells for phagocytic clearance. PS exposure is mediated in part by Ca2+-dependent lipid scramblases that flip lipids across the plasma membrane. Despite their importance in cell physiology, the molecular identity of the scramblases has eluded researchers for decades. Recently, TMEM16F, a member of the TMEM16 family of Ca2+-activated Cl- channels, was shown to be important for Ca2+-dependent PS exposure. Mutations in TMEM16F cause Scott syndrome, an inherited bleeding disorder associated with defective lipid scrambling in platelets. TMEM16F-null mice recapitulate this disorder, in addition to displaying other defects, such as decreased bone mineralization. Although TMEM16F is important for phospholipid scrambling in platelets, its role in the process remains unclear and controversial: it has been claimed to be a scramblase, an ion channel, or a dual function protein with both scramblase and channel activity. Our long-term goal is to elucidate the molecular bases of lipid scrambling by TMEM16F and its regulation by Ca2+. These insights will allow us to understand the etiology of Scott syndrome and the role of TMEM16F in this disease as well as in other processes. To achieve our overall goal we propose to identify the structural basis for
ion and lipid transport in TMEM16 proteins, determine the function and physiological role of TMEM16F and elucidate the molecular basis of Ca2+ sensing in TMEM16 proteins. Our approach is to combine biochemical assays on purified proteins with lipid scrambling and electrophysiological measurements of the same proteins in cells. We recently succeeded in expressing, purifying and functionally reconstituting TMEM16 proteins to demonstrate their intrinsic scramblase and channel activities. We also showed that expression of TMEM16F in cells indeed leads to ion transport and lipid scrambling. Thus, we have a strong platform of preliminary data to support our approach. Our proposal to understand lipid scrambling and the physiological functions of TMEM16 proteins is highly significant, as it will identify the molecular
basis of Scott syndrome and elucidate the fundamental mechanism of regulated transbilayer lipid transport, a process that is not understood in any system.
描述(由申请人提供):磷脂酰丝氨酸(PS)通常被隔离在质膜的内叶中,其表面暴露会引发活化血小板的血液凝固,并标记凋亡细胞以进行吞噬清除。 PS 暴露部分由 Ca2+ 依赖性脂质扰乱酶介导,这些脂质扰乱酶可翻转脂质穿过质膜。尽管它们在细胞生理学中很重要,但数十年来研究人员一直未能弄清楚它们的分子身份。最近,TMEM16F(Ca2+激活的Cl-通道TMEM16家族的成员)被证明对于Ca2+依赖性PS暴露很重要。 TMEM16F 突变会导致斯科特综合征,这是一种与血小板中脂质扰乱缺陷相关的遗传性出血性疾病。 TMEM16F 缺失的小鼠除了表现出其他缺陷(例如骨矿化减少)外,还重现了这种疾病。 尽管 TMEM16F 对于血小板中的磷脂扰乱很重要,但其在该过程中的作用仍不清楚且存在争议:它被声称是扰乱酶、离子通道或同时具有扰乱酶和通道活性的双功能蛋白。我们的长期目标是阐明 TMEM16F 脂质扰乱的分子基础及其 Ca2+ 的调节。这些见解将使我们能够了解 Scott 综合征的病因以及 TMEM16F 在这种疾病以及其他过程中的作用。 为了实现我们的总体目标,我们建议确定以下结构基础:
TMEM16 蛋白中的离子和脂质转运,确定 TMEM16F 的功能和生理作用,并阐明 TMEM16 蛋白中 Ca2+ 传感的分子基础。我们的方法是将纯化蛋白质的生化测定与细胞中相同蛋白质的脂质加扰和电生理学测量结合起来。我们最近成功表达、纯化和功能重建 TMEM16 蛋白,以证明其内在的扰乱酶和通道活性。我们还表明,细胞中 TMEM16F 的表达确实会导致离子转运和脂质扰乱。因此,我们拥有强大的初步数据平台来支持我们的方法。 我们关于了解脂质扰乱和 TMEM16 蛋白的生理功能的建议非常重要,因为它将识别分子
斯科特综合征的基础,并阐明了调节跨双层脂质转运的基本机制,这是任何系统中尚不了解的过程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alessio Accardi其他文献
Alessio Accardi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alessio Accardi', 18)}}的其他基金
Atomic basis for chloride channel and transporter gating and selectivity
氯离子通道和转运蛋白门控和选择性的原子基础
- 批准号:
10319992 - 财政年份:2019
- 资助金额:
$ 57.42万 - 项目类别:
Atomic basis for chloride channel and transporter gating and selectivity
氯离子通道和转运蛋白门控和选择性的原子基础
- 批准号:
10083219 - 财政年份:2019
- 资助金额:
$ 57.42万 - 项目类别:
Ca2+-dependent lipid scrambling and ion transport by TMEM16 proteins
TMEM16 蛋白的 Ca2 依赖性脂质扰乱和离子传输
- 批准号:
8860199 - 财政年份:2014
- 资助金额:
$ 57.42万 - 项目类别:
Ca2+-dependent lipid scrambling and ion transport by TMEM16 proteins
TMEM16 蛋白的 Ca2 依赖性脂质扰乱和离子传输
- 批准号:
10170367 - 财政年份:2014
- 资助金额:
$ 57.42万 - 项目类别:
Ca2+-dependent lipid scrambling and ion transport by TMEM16 proteins
TMEM16 蛋白的 Ca2 依赖性脂质扰乱和离子传输
- 批准号:
10624809 - 财政年份:2014
- 资助金额:
$ 57.42万 - 项目类别:
Ca2+-dependent lipid scrambling and ion transport by TMEM16 proteins
TMEM16 蛋白的 Ca2 依赖性脂质扰乱和离子传输
- 批准号:
10798983 - 财政年份:2014
- 资助金额:
$ 57.42万 - 项目类别:
Ca2+-dependent lipid scrambling and ion transport by TMEM16 proteins
TMEM16 蛋白的 Ca2 依赖性脂质扰乱和离子传输
- 批准号:
9238783 - 财政年份:2014
- 资助金额:
$ 57.42万 - 项目类别:
Ca2+-dependent lipid scrambling and ion transport by TMEM16 proteins
TMEM16 蛋白的 Ca2 依赖性脂质扰乱和离子传输
- 批准号:
10406928 - 财政年份:2014
- 资助金额:
$ 57.42万 - 项目类别:
Structure and function of chloride channels and transporters
氯离子通道和转运蛋白的结构和功能
- 批准号:
7802969 - 财政年份:2009
- 资助金额:
$ 57.42万 - 项目类别:
相似国自然基金
基于胺/硫醇一步溶液法制备多阴离子V-VI-VII硫卤化物薄膜太阳能电池
- 批准号:22309158
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于阴离子调控价态转移的光诱导铁催化聚烯烃的C(sp3)−H氧化氮化反应
- 批准号:22371223
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
手性氢键供体与阴离子结合催化乙烯基醚的立体选择性阳离子聚合
- 批准号:22301279
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
长链阴离子捕收剂对胺类捕收剂反浮选赤铁矿的优化及其泡沫调控机制
- 批准号:52364029
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
阴离子调控的Pd(0)催化烯烃亲核钯化反应研究
- 批准号:22301210
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Extended limb preservation employing an optimization strategy for stabilization.
采用优化稳定策略来延长肢体保护。
- 批准号:
10257524 - 财政年份:2021
- 资助金额:
$ 57.42万 - 项目类别:
Development of nanoparticulate solution for cancer treatment by breakup of tumor extracellular hydroxyapatite: a new paradigm
通过分解肿瘤细胞外羟基磷灰石来开发用于癌症治疗的纳米颗粒溶液:一个新范例
- 批准号:
10218793 - 财政年份:2021
- 资助金额:
$ 57.42万 - 项目类别:
Feasibility of expanding ischemia time for hearts destined for transplantation
延长移植心脏缺血时间的可行性
- 批准号:
10082625 - 财政年份:2020
- 资助金额:
$ 57.42万 - 项目类别:
Ca2+-dependent lipid scrambling and ion transport by TMEM16 proteins
TMEM16 蛋白的 Ca2 依赖性脂质扰乱和离子传输
- 批准号:
8860199 - 财政年份:2014
- 资助金额:
$ 57.42万 - 项目类别: